INTERNATIONAL PATENT: THE GENERAL HOSPITAL CORPORATION FILES APPLICATION FOR "DIFFERENTIATION OF PATIENTS WITH AND WITHOUT PROSTATE CANCER USING URINE 1H NMR METABOLOMICS"

GENEVA, Feb. 19 -- THE GENERAL HOSPITAL CORPORATION (55 Fruit StreetBoston, MA 02114) filed a patent application (PCT/US2024/040964) for "DIFFERENTIATION OF PATIENTS WITH AND WITHOUT PROSTATE CANCER USING URINE 1H NMR METABOLOMICS" on Aug 05, 2024. With publication no. WO/2025/034663, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHENG, Leo, L. (12 Grove StreetUnit 1Waltham, MA 02453), FELDMAN, Adam (29 Lovett RoadNewton, MA 02459)

Abstract: The invention relates to a method of diagnosing a subject with prostate canc...